| 08.08 12:31 | EQS-News: Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update |
| 08.08 12:31 | EQS-News: Immunic, Inc. Reports Second Quarter -2- |
| 08.08 12:30 | EQS-News: Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update |
| 08.08 12:30 | EQS-News: Immunic, Inc. Reports Second Quarter -2- |
| 08.08 12:30 | dpa-AFX: EQS-News: Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update (english) |
| 01.08 12:31 | EQS-News: Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update |
| 01.08 12:30 | dpa-AFX: EQS-News: Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update (english) |
| 01.08 12:30 | EQS-News: Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update |
| 24.07 12:31 | EQS-News: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec |
| 24.07 12:30 | dpa-AFX: EQS-News: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec (english) |
| 24.07 12:30 | EQS-News: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec |
| 10.10 15:43 | MÄRKTE USA/Aktien starten gut behauptet - Anleihen fest |
| 10.10 14:40 | MÄRKTE USA/Aktien gut behauptet erwartet - Anleihen fest |
| 10.10 08:32 | dpa-AFX: *IMMUNIC BEI TRADEGATE +47% VS NASDAQ - ZWISCHENERGEBNISSE AUS MS-STUDIE |
|
|
